Cresco Labs Inc.
corporate_fare Company Profile
Cresco Labs Inc. (OTC:CRLBF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 6 items for CRLBF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-30, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for CRLBF spans 6-K.
Recent high-impact activity:
- Cresco Labs Proposes Reverse Split, Delaware Redomicile, and Extended Dual-Class Sunset
- Cresco Labs Q2 Revenue Hits $173M, Adjusted EBITDA $40M; CFO Steps Down Amid Federal Rescheduling Tailwind
- Cresco Labs Reports Q1 Loss Amid Revenue Decline; Highlights Transformative Cannabis Rescheduling & Strategic Expansion
- Medical Cannabis Rescheduling to Schedule III Powers Cresco Labs' Q1 Growth
- Cresco Labs Posts $162M Q4 Revenue, Boosts Margins Sequentially
Financial Snapshot
Short Interest & Short Volume
1.15 days to coverFINRA reported short interest of 1,015,351 shares in CRLBF as of the September 15, 2026 settlement, a 12.0% decrease from the prior period — about 1.1 days to cover at its recent average daily volume. On October 2, 2026, 53.6% of CRLBF volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
CRLBF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.